Israel Considering Combating Measles With Earlier Vaccines For 2-Year-Olds

>>Follow Matzav On Whatsapp!<<

A committee of experts in infectious diseases suggested the Health Ministry offer children the second dose of the measles, mumps, rubella, and varicella (MMRV) vaccine at two years instead of in first grade, in order to battle the disease and help prevent the next outbreak, Israel Hayom reported.

Members of the committee noted that giving an additional dose of the vaccine at the Tipat Chalav clinics requires additional staff. They also noted that for a period of several years, the second dose will need to be offered both at two years, by the clinics, and at six years, in schools. During these period, there will be a need for an additional temporary budget.

Since February, Israel has seen 787 documented cases of measles. However, experts believe that there is severe under-reporting. According to Ynet, the majority of measles cases are not reported to the Health Ministry

Read more at Arutz Sheva.



  1. Vaccines are the backbone of the entire pharmaceutical industry. If they can make these children sick from a very early age, they become customers for life.
    The money isn’t really to be made in the vaccine industry. The money is made by big pharma with all of the drugs that are given to treat and address all the illnesses that are subsequent to the side effects of the vaccines.


Please enter your comment!
Please enter your name here